Company / Financials
Zomedica Corp. Financials
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$32.0M
FY2025 · +17.4% YoY
Net Income
-$81.9M
FY2025 · -74.2% YoY
Profit Margin
-255.6%
FY2025 · net income / revenue
ROE
-70.9%
FY2025 · return on equity
Total Assets
$127.0M
FY2025
Total Debt
-
FY2025
Equity
$115.4M
FY2025
ROA
-64.4%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$32.0M+17.4% YoYNet Income HistoryProfit after all expenses and taxes-$81.9M-74.2% YoYGross Profit HistoryRevenue minus cost of goods sold$21.7M+13.6% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$10.4M+26.3% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$84.4M-65.2% YoYSG&A Expense HistorySelling, general, and administrative expenses$24.5M-17.4% YoYR&D Expense HistoryResearch and development spending$7.2M-1.4% YoYInterest Expense HistoryCost of borrowing and debt obligations-Income Tax HistoryTotal income tax expense-$278.0K+50.1% YoYEPS (Basic) HistoryBasic earnings per share-$0.05-25.0% YoY